down-regulation of Leydig cells have been demonstrated in vitro, which should facilitate the elucidation of the mechanisms involved. Initial experiments indicate that specific proteins may play a role in the desensitization of the Leydig-cell plasma membrane. Whether or not cyclic AMP-mediated processes are also involved in this process remains to be determined.
lutropin-dose-dependent process, and both loss of lutropin receptors and adenylate cyclase activity occur concomitantly. Both these processes are apparently dependent on protein synthesis. In addition, initially lutropin-independent increases in choriogonadotropin binding and basal cyclic AMP production occur which are not dependent on protein synthesis. These latter observations may be relevant to previous studies in which it was shown that preincubating normal Leydig cells for several hours in vitro after isolation and purification from rat testes brought about changes in their properties with respect to their subsequent responses to lutropin. For example, the time taken to detect lutropin-stimulated testosterone synthesis is less than 5 min in preincubated cells, compared with 30min for nonpreincubated cells (Cooke et al., 1977) . In preincubated Leydig cells, there is also a reproducible and significant stimulation of cyclic AMP-dependent protein kinase activation with all amounts of lutropin that submaximally stimulate testosterone production (Cooke et al., 1976) . Finally, in preincubated Leydig cells, but not in freshly prepared cells, lutropin-stimulated testosterone production is initially independent of RNA synthesis de novo (Cooke et al., 1979a) .
So far as is known, lutropin is the only factor that directly controls Leydig-cell steroidogenesis. However, it is becoming apparent that other hormones, not dealt with here, such as oestradiol-l7/3, prolactin, insulin etc. may in some way modify the lutropin-receptor turnover and steroidogenic pathways. It is also possible that local factors present in the testis may modify the Leydig cells; the elucidation of the etiology of the different Leydig cell types may be important in this respect. Local factors have been shown to modify testis Sertoli-cell activity (Boitani & Ritzen, 1980) , so it is not unreasonable to propose that this may also occur with Leydig cells. These aspects require further investigation. The results of the present study have shown that it is possible to obtain pure Leydig cells of defined physical and biochemical characteristics that can be used for studies in vitro into the mechanism of lutropin action. Desensitization and
The role of cyclic AMP as the second messenger of hormone and neurotransmitter stimulations has been widely demonstrated. The transmission -of the signal from the extracellular milieu to the inside of the cell has been intensively studied, and a detailed minimal molecular mechanism of adenylate cyclase activation can be proposed on the basis of recent discoveries. The numerous possible interactions between the main components of this system render the intuitive interpretation of some experiments quite complex. Therefore the model appears to be a valuable tool for improving the description of the system. Moreover, the predictions of the consequences of a given model require demonstrations as rigorous as the experimental protocols used for the study of the system. Simulations serve such a purpose. The aim of this paper is to present the model that we currently use for theoretical simulation, to describe the successive steps involved in the adenylate cyclase activation in terms of the molecular interactions defined in the model, and to list some known experimental behaviour by this system that can be accounted for by the proposed model. An extensive analysis of this model has been presented elsewhere (Swillens & Dumont, 1980a,b) .
The model
The proposed model is a slightly expanded version of the cyclic model of Cassel & Selinger (1978) . It describes the interactions between the three main components of the system, namely the receptor R, the guanine nucleotide-binding protein G and the adenylate cyclase E. It is assumed that the three components can exist in two conformations, an active form (marked by an asterisk) and an inactive form. The activation state of any component is thus given by the relative proportion of the two conformations and is governed by the relative rates of the on-process (inactive -active) and of the off-process (active -inactive). The model presented in Fig. 1 is subdivided into three submodels, each of them having respectively R. G or E as the central component.
The R-model is based on a general scheme of drug-receptor interaction (Weiland et al.. 1979) involving the binding of hormone to the receptor and the isomerization of this complex into the active form of the receptor.
Experimental observations (Pfeuffer, 1979) suggested that the binding of adenylate cyclase E to the G-unit is facilitated when GTP is associated with the G-unit, whereas GDP-associated G-unit is weakly bound to E. The adenylate cyclase is in the active form only when bound to the active G-unit. Thus the activation of E occurs as a result of GTP binding to G. The inactivation of E is the consequence of the hydrolysis of GTP by the G-unit. This is expressed by the E-model (Fig. I on current knowledge of the b-adrenergic system Abbreviations: H, hormone; R, receptor; E, adenylate cyclase; G, guanine. nucleotide-binding protein (G, G, and G, refer to free G. GDP-bound G and GTP-bound G respectively). The active species are marked by an asterisk. The length of the arrows is related to the kinetics of the reaction.
The transducer process which couples the signal (hormone binding) to the response (adenylate cyclase activation) is defined by the G-model (Fig. 1) . The G-unit can exist in three physiological states, i.e. the guanine nucleotide-binding site is unoccupied (G). or occupied by GDP (G,) or by GTP (GT). The only active form would be GT. According to the cyclic model of Cassel & Selinger (1978), hormone-receptor complex binds to the G-unit and facilitates the exchange of G D P with GTP. In the absence of hormone a pre-equilibrium between G,, G and G: could exist.
Mechanistic description of the model
The extent of adenylate cyclase activity mainly depends on the amount of active G-unit (GT). Thus the adenylate cyclase activity is controlled by the cyclic process of G-unit activation and inactivation (G-model). In the absence of hormone, the on-process consists of G D P dissociation (reaction 10) and GTP association (reaction I I), whereas the off-process is accounted for by the GTPase activity (reaction 8). A relatively slow on-process compared with the off-process leads to a steady state where inactive G-unit (G,) is more abundant than active G-unit ((3; ). and thus only a small part of the adenylate cyclase activity is expressed. One possibility to increase the adenylate cyclase activity is to increase the rate of the on-process. This is the role of the HR* interaction with the G-unit (Cassel & Selinger, 1978) . As shown in the model, the binding of HR* to G, (reaction 3) facilitates the exchange of G D P by GTP (reactions 4 and 5) and thus accelerates the formation of active G-unit. In such conditions, the on-process can overwhelm the off-process, leading to the accumulation of active G-unit. The other possibility to favour the accumulation of active G-unit is to slow down the rate of the off-process by inhibiting the GTPase activity (reaction 8) by using cholera toxin (Cassel & Selinger, 1977) . Likewise, non-hydrolysable analogues of GTP are more potent effectors than GTP in activating the G-unit and thus adenylate cyclase. because reaction 8 is not operating with such analogues.
It has been widely reported that P-adrenergic receptors, for instance, can recognize different classes of molecules characterized by their respective abilities in activating adenylate cyclase despite the full occupation of the receptors; full agonists exhibit high efficacy, whereas antagonists cannot activate the system (zero efficacy); partial agonists exhibit intermediate efficacies. Such properties can be explained by the respective capabilities of these drugs at saturating concentration to accelerate the on-process (Perkins et al., 1979; Arad & Levitzki, 1979) . Within the framework of the proposed model, such an effect results from different characteristics of the isomerization equilibrium (reaction 2). An agonist exhibits a high efficacy if it can induce a high accumulation of active HR* complex and consequently, of active G-unit. Antagonist would not induce receptor activation on isomerization and thus cannot modulate adenylate cyclase activity. According to the collision-coupling concept (Tolkovsky & Levitzki, 1978) , the HR*G complex does not accumulate in the presence of guanine nucleotide (Limbird & Lefkowitz, 1978) . Therefore, in this condition, the association of HR* with the G-unit cannot affect the equilibrium of reactions 1 and 2 and thus the concentration of HR* at saturating concentration of agonist is only governed by the equilibrium constant of reaction 2, which depends on the nature of the agonist.
Properties of the model and experimental behaviour
The chief purpose of theoretical simulation is to verify if a model elaborated an the basis of experimental facts can account for observed behaviours. We can demonstrate that several behaviours of the p-adrenergic system can be generated by numerical simulations of the model.
(i) Addition of GTP lowers the apparent G n i t y of agonist binding to the receptor, but has no effect on antagonist binding (Maguire et a/., 1976). As experimentally shown (Limbird & Lefkowitz, 1978) , the model suggests that the complex HR* is more tightly bound to free G than to guanine nucleotideassociated G-unit, i.e. the dissociation constant of reaction 12 is much lower than the dissociation constants of reactions 3 and 6. Thus, in the absence of guanine nucleotide, the formation of HR*G stabilizes the binding of H to R and thus increases the apparent binding affinity of the agonist. The presence of guanine nucleotides destabilizes the complex HR*G and facilitates the dissociation of H, resulting in an apparent decrease of agonist binding affinity. Since antagonist would not induce any interaction between R and G, guanine nucleotides cannot affect antagonist binding.
(ii) Agonist binding obeys Michaelian kinetics in the presence of GTP, whereas the binding appears to be negatively co-operative in the absence of GTP (Maguire et al., 1976) ; antagonist binding is again independent of guanine nucleotide addition and is non-co-operative. As antagonist binding is described by reaction 1 and not by reaction 2, it is characterized by Michaelian kinetics, as expected. In the absence of guanine nucleotide, agonist binding is described by a two-step model (Jacobs & Cuatrecasas, 1976; Boeynaems & Dumont, 1977) , where the first step is the hormone binding to the receptor and the possible conformational change of the receptor (reactions 1 and 2), and the second step is the HR* binding to the G-unit (reaction 12). It is well known that such a model exhibits apparent negative co-operativity if the complex HR*G accumulates. On the other hand, this complex is highly unstable in the presence of guanine nucleotide (Limbird & Lefkowitz, 1978) , and thus cannot accumulate. In this case non-cooperative binding occurs because the second step is not operative.
( (Swillens & Dumont, 1980b) , such a model always generates K,,/K, values less than 1, where K , and K, refer to the agonist concentrations necessary for half-maximal activation and half-maximal binding respectively. Moreover, simulation can show that the more active the agonist in activating the adenylate cyclase, the larger the discrepancy between K A and K,. Thus the model is in agreement with the observed non-linear coupling between receptor occupancy and agonist effect.
Conclusion
The available data on the elements of the adenylate cyclase system have been summarized in the proposed model. This model has been simulated in order to verify if complex behaviour can be explained on the basis of theoretical considerations. For instance, GTP effects on agonist and antagonist binding and the discrepancy between K A and K, can be accounted for by the model. These results can be used as a theoretical support to intuitive interpretations of observed behaviour and can predict consequences of the experimental modulation of different parameters of the model. This work has been performed under contract of the Ministere de la Politique Scientifique (Actions Concertees).
